Aurobindo Pharma Ltd has signed an agreement to buy 20 per cent stake additional stake in vaccine developer Tergene Biotech Pvt. Ltd for Rs.5.65 crores ($885,000). Tergene Biotech is a joint venture between Aurobindo Pharma and the promoters of Hyderabad-based Tergene.